263 related articles for article (PubMed ID: 781380)
41. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
42. Complement deposition in glomerular diseases.
di Belgiojoso GB; Tarantino A; Durante A; Guerra L
Proc Eur Dial Transplant Assoc; 1975; 11():515-21. PubMed ID: 1105561
[TBL] [Abstract][Full Text] [Related]
43. Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis.
Wyatt RJ; McAdams AJ; Forristal J; Snyder J; West CD
Kidney Int; 1979 Oct; 16(4):505-12. PubMed ID: 398417
[TBL] [Abstract][Full Text] [Related]
44. Recurrence of membranoproliferative glomerulonephritis following kidney transplantation. Serum complement component studies.
McLean RH; Geiger H; Burke B; Simmons R; Najarian J; Vernier RL; Michael AF
Am J Med; 1976 Jan; 60(1):60-72. PubMed ID: 766620
[TBL] [Abstract][Full Text] [Related]
45. Paramesangial glomerular deposits in membranoproliferative glomerulonephritis type II correlate with hypocomplementemia.
West CD; McAdams AJ
Am J Kidney Dis; 1995 Jun; 25(6):853-61. PubMed ID: 7771481
[TBL] [Abstract][Full Text] [Related]
46. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
Hiramatsu M; Balow JE; Tsokos GC
J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
[TBL] [Abstract][Full Text] [Related]
47. Measles infection. Involvement of the complement system.
Charlesworth JA; Pussell BA; Roy LP; Robertson MR; Beveridge J
Clin Exp Immunol; 1976 Jun; 24(3):401-6. PubMed ID: 939047
[TBL] [Abstract][Full Text] [Related]
48. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
49. Characterization of mixed membranous and proliferative glomerulonephritis: recognition of three varieties.
Burkholder PM; Hyman LR; Krueger RP
Perspect Nephrol Hypertens; 1973; 1 Pt 1():557-89. PubMed ID: 4620927
[No Abstract] [Full Text] [Related]
50. Serum and glomerular complement in 205 cases of glomerulonephritis.
Durante A; Rovati C; di Belgiojoso GB; Minetti L
Proc Eur Dial Transplant Assoc; 1976; 12():189-96. PubMed ID: 935112
[TBL] [Abstract][Full Text] [Related]
51. Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): relationship between the high frquency of recurrent glomerulonephritis and hypocomplementemia.
Berthoux FC; Ducret F; Colon S; Blanc-Brunat N; Zech PY; Traeger J
Kidney Int Suppl; 1975 Feb; (3):323-7. PubMed ID: 1099312
[No Abstract] [Full Text] [Related]
52. Serum complement components in Henoch-Schönlein purpura.
Garcia-Fuentes M; Martin A; Chantler C; Williams DG
Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
[TBL] [Abstract][Full Text] [Related]
53. Complement deficiency states.
Agnello V
Medicine (Baltimore); 1978 Jan; 57(1):1-23. PubMed ID: 337041
[No Abstract] [Full Text] [Related]
54. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
55. Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.
Blom AM; Corvillo F; Magda M; Stasiłojć G; Nozal P; Pérez-Valdivia MÁ; Cabello-Chaves V; Rodríguez de Córdoba S; López-Trascasa M; Okrój M
J Clin Immunol; 2016 Jul; 36(5):517-27. PubMed ID: 27146825
[TBL] [Abstract][Full Text] [Related]
56. Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3.
Linshaw MA; Stapleton FB; Cuppage FE; Forristal J; West CD; Schreiber RD; Wilson CB
Am J Nephrol; 1987; 7(6):470-7. PubMed ID: 3326412
[TBL] [Abstract][Full Text] [Related]
57. Metabolism of properdin in normal subjects and patients with renal disease.
Ziegler JB; Rosen FS; Alper CA; Grupe W; Lepow IH
J Clin Invest; 1975 Sep; 56(3):761-7. PubMed ID: 1159085
[TBL] [Abstract][Full Text] [Related]
58. [The complement system].
Lambert PH
Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
[TBL] [Abstract][Full Text] [Related]
59. Dense deposit disease: a variant of membranoproliferative glomerulonephritis.
Habib R; Gubler MC; Loirat C; Mäiz HB; Levy M
Kidney Int; 1975 Apr; 7(4):204-15. PubMed ID: 1095806
[No Abstract] [Full Text] [Related]
60. Nephritic factor: Description of a new quantitative assay and findings in glomerulonephritis.
Border WA; Wilson CB; Götze O
Kidney Int; 1976 Oct; 10(4):311-8. PubMed ID: 62864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
